FDA
Lopinavir; Ritonavir
The FDA lists this product in 6 strengths and forms.
Composition
- Active ingredients
- LOPINAVIR 200MG; RITONAVIR 50MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- LOPINAVIR 100MG; RITONAVIR 25MG · TabletANDA090471-001 · Tentative approval
- LOPINAVIR 200MG; RITONAVIR 50MG · TabletANDA090471-002 · Tentative approval
- LOPINAVIR 80MG; RITONAVIR 20MG · SolutionANDA091203-001 · Tentative approval
- LOPINAVIR 200MG; RITONAVIR 50MG · TabletANDA091202-002 · Tentative approval
- LOPINAVIR 100MG; RITONAVIR 25MG · TabletANDA091202-001 · Tentative approval
- LOPINAVIR 200MG; RITONAVIR 50MG · TabletThis page
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA090371.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Lopinavir; Ritonavir
- Active substance
- lopinavir
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Cipla Limited
- Status
- Tentative approval
- FDA approval
- 20 Nov 2009
- Application
- ANDA090371-001